Emphysema Treatment Market to Grow with a CAGR of 5.68% through 2028
Advances in minimally
invasive procedures and biologics are expected to drive the Global Emphysema
Treatment Market growth in the forecast period, 2024-2028.
According to TechSci
Research report, “Emphysema Treatment Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2028”, the Global Emphysema
Treatment Market stood at USD 4.21 billion in 2022 and is anticipated to grow
with a CAGR of 5.68% in the forecast period, 2024-2028. The Global Emphysema
Treatment Market is experiencing significant growth, driven by several key
market drivers. Emphysema, a debilitating chronic obstructive pulmonary disease
(COPD), affects millions of individuals worldwide and poses a substantial
healthcare burden. One of the
primary drivers boosting the global emphysema treatment market is the
continuous advancements in medical technology. Traditional treatments for
emphysema include medications, oxygen therapy, and pulmonary rehabilitation.
However, recent breakthroughs have introduced minimally invasive procedures
that are changing the landscape of emphysema treatment. Bronchoscopic lung
volume reduction (BLVR) is a prime example of such innovation. BLVR procedures
involve the insertion of small devices or materials into the airways to block
off or reduce airflow to damaged areas of the lungs. These procedures aim to
improve lung function and alleviate symptoms, offering a ray of hope to
patients with severe emphysema who were previously deemed untreatable.
Another notable
technological advancement is the development of biologics and targeted
therapies. These drugs are designed to address specific pathways and mechanisms
involved in emphysema progression. By targeting these pathways, biologics can
slow down the disease's progression and improve patients' quality of life. Such
innovations are not only effective but also less invasive compared to
traditional treatments.
The global
prevalence of emphysema is on the rise, contributing significantly to the
growth of the emphysema treatment market. Emphysema is primarily caused by
long-term exposure to tobacco smoke, environmental pollutants, and other risk
factors. With the global population aging and increased exposure to these risk
factors, the incidence of emphysema is expected to continue climbing. Moreover,
the link between emphysema and other health conditions, such as heart disease
and diabetes, underscores the urgency of addressing this disease. Healthcare professionals
are increasingly recognizing the importance of early diagnosis and effective
treatment in managing emphysema and its associated comorbidities. This growing
awareness is driving both patients and healthcare providers to seek out and
invest in advanced treatment options.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "Emphysema Treatment Market.”
The Global
Emphysema Treatment Market is segmented into Treatment, End User, Distribution Channel, Regional Distribution, And
Company.
Based
on the Treatment, Smoking Cessation emerged as the dominant segment in the
global market for Global Emphysema Treatment Market in 2022. Smoking cessation
is often recommended as part of a comprehensive emphysema treatment plan. It
complements other therapies, such as bronchodilators and steroids, by
addressing the underlying cause of disease exacerbation. Smoking cessation is
considered the most effective and primary preventive measure for emphysema.
Since the leading cause of emphysema is long-term exposure to tobacco smoke,
stopping smoking is crucial in preventing the disease from developing or
progressing further. This has led to a significant emphasis on smoking
cessation programs and interventions. Smoking cessation is relatively
cost-effective when compared to other emphysema treatments like gene therapy,
surgery, or lung transplantation. This affordability makes it a practical
choice for healthcare systems and individuals, especially when considering the
long-term costs associated with managing emphysema.
Based on the
End-User, the Hospitals and clinics segment emerged as the dominant player in
the global market for Global Emphysema Treatment Market in 2022. Hospitals and
clinics often have specialized departments and healthcare professionals
dedicated to respiratory diseases like emphysema. These facilities provide a
comprehensive range of diagnostic, treatment, and management services, making
them the preferred choice for patients seeking specialized care. Emphysema
patients may experience acute exacerbations of their condition, leading to
severe respiratory distress. Hospitals are equipped to handle these
emergencies, providing immediate medical intervention, oxygen therapy, and
other life-saving measures. This acute care capability is vital for emphysema
patients during exacerbations. Hospitals and
clinics often have access to advanced diagnostic tools, such as high-resolution
computed tomography (HRCT) scans and pulmonary function tests, which are
crucial for accurately diagnosing and assessing the severity of emphysema.
Based on the
Distribution Channel, the Retail pharmacy segment emerged as the dominant
player in the global market for Global Emphysema Treatment Market in 2022.
Retail pharmacies are easily accessible to a vast majority of the population,
whether in urban or rural areas. Patients with emphysema and other respiratory
conditions often require regular access to medications and therapies. Retail
pharmacies provide a convenient option for patients to obtain their
prescriptions and medical supplies, promoting treatment adherence. Retail
pharmacy chains have a broad network of outlets, making it easy for patients to
find a nearby pharmacy. This wide coverage ensures that emphysema medications
and treatment supplies are readily available to patients across various
geographical locations, both in cities and rural areas.
North America
emerged as the dominant player in the global Emphysema Treatment Market in
2022, holding the largest market share. North America, particularly the United
States, has a significant prevalence of emphysema and other chronic obstructive
pulmonary diseases (COPD). This high disease burden contributes to a
substantial demand for emphysema treatment options, driving the market's growth.
North America boasts advanced healthcare infrastructure, including
well-equipped hospitals, specialized clinics, and a network of healthcare
providers. This infrastructure supports the diagnosis, treatment, and
management of emphysema with the latest medical technologies and therapies. The
region is a hub for pharmaceutical and biotechnology companies, conducting
extensive research and development in respiratory medicine. This focus on
innovation leads to the development of new emphysema treatment modalities,
creating a robust market.
Major companies
operating in Global Emphysema Treatment Market are:
- Icure Pharmaceuticals Inc.
- AstraZeneca Plc.
- Teva Pharmaceuticals Industries Ltd.
- Novartis AG
- GlaxoSmithKline Plc.
- Hikma Pharmaceuticals Plc
- Boehringer Ingelheim International
GmbH
- Mylan N.V.
- Pfizer Inc.
- Orion Corporation
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“The
Global Emphysema Treatment Market is poised for significant growth in the
coming years. Emphysema, a debilitating form of chronic obstructive pulmonary
disease (COPD), continues to affect a substantial portion of the global
population, particularly in regions with high smoking rates and environmental
pollutants. Several factors are expected to drive this growth, including the
rising prevalence of emphysema due to aging populations and increased exposure
to risk factors. Additionally, advancements in medical technology, such as
minimally invasive procedures and biologics, offer more effective and
patient-friendly treatment options. Increased awareness about emphysema and its
early diagnosis, along with the expansion into emerging markets, further
contribute to the market's expansion.” said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based management consulting firm.
“Emphysema
Treatment Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2018-2028 Segmented By Treatment (Smoking Cessation, Bronchodilators,
Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene
Therapy, Surgery Transplant, Other Treatments), By Distribution Channel
(Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels), By End-User
(Hospitals & Clinics, Ambulatory care Centres, Others) By Region and
Competition”, has evaluated the future growth potential of Global
Emphysema Treatment Market and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Emphysema
Treatment Market.
Contact
Mr. Ken Mathews
708 Third
Avenue,
Manhattan, NY,
New
York 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com